The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
their utility are that you know they can help you achieve a glucose ketone index and when you do have a glucose can ketone index of one to two you are limiting fermentable fuels to the cancer cells and also most likely suppressing the hormone insulin tremendously
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Achieve and maintain a glucose ketone index of 1 to four. So that's the millimmer concentration of glucose over ketones. So if your glucose was four, which is relatively normal and >> and your ketone levels were one, you know, which is the entry of that zone >> where I'm at now. So that gives me a GKI of four.
So achieve a GKI of 1 to four, maintain that and then you go and aggressively target glucose and glutamine. So you could target glucose with lonitamine. It's a hexokinise inhibitor, three brooyrovate, two deoxylucose, you can use an SGLT2 inhibitor, you can use I mean we have about two dozen different drugs that you could use and off-the-shelf kind of things like SGLT2.